These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 16782927

  • 1. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP.
    J Clin Oncol; 2006 Jun 20; 24(18):2879-84. PubMed ID: 16782927
    [Abstract] [Full Text] [Related]

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Jun 20; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 3. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Newman K, Finegold MJ, Haas JE, Sensel MG, Castleberry RP, Bowman LC.
    Cancer; 2003 Apr 15; 97(8):2006-12. PubMed ID: 12673731
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G.
    J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943
    [Abstract] [Full Text] [Related]

  • 5. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
    Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, Haas JE, King DR, Liu-Mares W, Sensel MG, Krailo MD.
    J Clin Oncol; 2000 Jul 20; 18(14):2665-75. PubMed ID: 10894865
    [Abstract] [Full Text] [Related]

  • 6. [Outcome of hepatoblastoma: experience with 63 patients received chemotherapy with the regimen C5V].
    Liu G, Liu B, Li K, Dong K, Xiao X.
    Zhonghua Er Ke Za Zhi; 2015 Feb 20; 53(2):119-23. PubMed ID: 25876687
    [Abstract] [Full Text] [Related]

  • 7. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H.
    Klin Padiatr; 1999 Feb 20; 211(4):305-9. PubMed ID: 10472567
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS, Devidas M, Jenkins J, Rao B, Marcus R, Thomas P, Gebhardt M, Pratt C, Grier HE.
    J Clin Oncol; 2005 Jun 20; 23(18):4031-8. PubMed ID: 15767644
    [Abstract] [Full Text] [Related]

  • 9. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
    Katzenstein HM, London WB, Douglass EC, Reynolds M, Plaschkes J, Finegold MJ, Bowman LC.
    J Clin Oncol; 2002 Aug 15; 20(16):3438-44. PubMed ID: 12177104
    [Abstract] [Full Text] [Related]

  • 10. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A.
    Cancer; 2002 Feb 15; 94(4):1111-20. PubMed ID: 11920482
    [Abstract] [Full Text] [Related]

  • 11. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
    Carceller A, Blanchard H, Champagne J, St-Vil D, Bensoussan AL.
    J Pediatr Surg; 2001 May 15; 36(5):755-9. PubMed ID: 11329582
    [Abstract] [Full Text] [Related]

  • 12. Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group.
    Katzenstein HM, Chang KW, Krailo M, Chen Z, Finegold MJ, Rowland J, Reynolds M, Pappo A, London WB, Malogolowkin M, Children's Oncology Group.
    Cancer; 2009 Dec 15; 115(24):5828-35. PubMed ID: 19813275
    [Abstract] [Full Text] [Related]

  • 13. Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.
    Sivaprakasam P, Gupta AA, Greenberg ML, Capra M, Nathan PC.
    J Pediatr Hematol Oncol; 2011 Aug 15; 33(6):e226-30. PubMed ID: 21792028
    [Abstract] [Full Text] [Related]

  • 14. [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
    Pan C, Tang JY, Chen J, Xue HL, Dong L, Zhou M, Jiang H, Ye QD, Gu LJ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug 15; 11(8):659-62. PubMed ID: 19695195
    [Abstract] [Full Text] [Related]

  • 15. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
    Li JP, Chu JP, Yang JY, Chen W, Wang Y, Huang YH.
    Cardiovasc Intervent Radiol; 2008 Aug 15; 31(6):1117-23. PubMed ID: 18560935
    [Abstract] [Full Text] [Related]

  • 16. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
    Casanova M, Massimino M, Ferrari A, Spreafico F, Piva L, Coppa J, Luksch R, Cefalo G, Terenziani M, Polastri D, Bellani FF, Mazzaferro V.
    Pediatr Hematol Oncol; 2005 Aug 15; 22(3):189-98. PubMed ID: 16020101
    [Abstract] [Full Text] [Related]

  • 17. Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer.
    Socinski MA, Weissman C, Hart LL, Beck JT, Choksi JK, Hanson JP, Prager D, Monberg MJ, Ye Z, Obasaju CK.
    J Clin Oncol; 2006 Oct 20; 24(30):4840-7. PubMed ID: 17050869
    [Abstract] [Full Text] [Related]

  • 18. Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group.
    Cacciavillano WD, Brugières L, Childs M, Shafford E, Brock P, Pritchard J, Mailbach R, Scopinaro M, Perilongo G.
    Eur J Cancer; 2004 Oct 20; 40(15):2274-9. PubMed ID: 15454253
    [Abstract] [Full Text] [Related]

  • 19. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D, Golubicic I, Gavrilovic D, Kezic I, Jelic S.
    J BUON; 2009 Oct 20; 14(2):203-9. PubMed ID: 19650167
    [Abstract] [Full Text] [Related]

  • 20. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, Superina RA.
    J Pediatr Surg; 2008 Nov 20; 43(11):1973-81. PubMed ID: 18970927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.